Recon: Trump administration boosts 2026 Medicare Advantage payments; Federal commission urges U.S. to invest $15B in biotech to counter China

Recon

ReconJason Scott

Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States